Clinical Trial Update: Study of Blood Components as Probable Prognostic and Predictive Markers of Response to Treatment in Advanced Colon and Rectal Cancers

View source ↗

Summary

Clinical trial evaluating blood components as prognostic and predictive markers of response in advanced colon and rectal cancers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Rectal Cancer

Snippet

Sponsor: AC Camargo Cancer Center | Conditions: Colon Cancer Stage IIb, Rectum Cancer, Adenocarcinoma | Status: UNKNOWN